Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of ...
Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...
Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...
People with MS are more than twice as likely to experience headaches, including migraines, than their healthy counterparts, ...
Research presented recently at the ECTRIMS Congress 2025 highlights the patient perspective on menopause and MS.
News-Medical.Net on MSN
Estradiol and estriol may protect nerve function in multiple sclerosis
About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of ...
So declared Selma Blair on stage at Flow Space Women's Health Summit in Los Angeles on Oct. 9, where the actress spoke about ...
News-Medical.Net on MSN
Discovery explains why women face higher risk of Alzheimer’s and multiple sclerosis
New research by UCLA Health has identified a sex-chromosome linked gene that drives inflammation in the female brain, ...
A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the ...
US Weekly on MSN
Selma Blair Recalls Doctors Dismissing Her Early Multiple Sclerosis Symptoms as a Teen
Selma Blair’s lifelong health struggles were signs of multiple sclerosis that doctors wouldn't acknowledge until she was in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback